Search
for
Sort by
Research 151–180 of 493
- Recent advances in understanding of radiation-induced skin tissue reactions with respect to acute tissue injury and late adverse effect
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- TGFβ and cancer metastasis: an inflammation link
- Immunology of the Human Nail Apparatus: The Nail Matrix Is a Site of Relative Immune Privilege
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Alopecia areata – Current understanding and management
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Understanding the Association Between Mental Health and Hair Loss
- Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- 1317 Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Evidence for the off-label use of tofacitinib in alopecia areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- 596 Application of an artificial intelligence (AI) photographic device to track platelet-rich plasma treatment outcomes in females with alopecia
- Increase in IL-15 levels in patients with alopecia areata
- Epidemiology and burden of alopecia areata: a systematic review
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis